Orient Paper reports FY26 revenue of Rs. 906 crores
Orient Paper & Industries Limited reported a revenue of Rs. 906 crores for FY26, a marginal increase over the previous year, alongside a net loss of Rs. 29 crores. Operational highlights included record production in its paper and chemical businesses, though average prices declined by approximately 6%. The company launched Project Sankalp to enhance cost competitiveness, targeting annualized savings of Rs. 40 crores, and plans to add a new Tissue-4 machine with 23,400 TPA capacity.

*this image is generated using AI for illustrative purposes only.
Orient Paper & Industries Limited reported a revenue of Rs. 906 crores for the financial year ended March 31, 2026, reflecting a marginal improvement over the previous year, alongside a net loss of Rs. 29 crores. The company achieved positive cash flow in Q4 FY26, marking its first such achievement in nine quarters, and launched Project Sankalp to drive operational excellence and cost savings.
The company’s paper business recorded its highest ever production, increasing by 2.3% over the previous year, while the chemical business saw production rise by 6.7%. Despite these operational gains, average prices dropped by approximately 6% compared to FY25, with the Writing & Printing segment seeing a 4% price drop and the tissue segment a sharper 7.5% decline. The product mix comprised 62% Writing & Printing paper and 38% tissue products, with value-added products representing 55% of the overall mix.
To strengthen its cost competitiveness, the company initiated Project Sankalp, a series of high-impact initiatives focused on key cost levers. These measures are expected to generate annualized savings of approximately Rs. 40 crores. Additionally, the company faced raw material sourcing cost pressures due to transit permit restrictions in Madhya Pradesh, which led to a 7% increase in sourcing costs before the state government removed Eucalyptus from the list of products requiring transit permits later in the year.
Looking ahead, the company plans to establish a new Tissue-4 machine with an additional capacity of 23,400 TPA to support its strategy of increasing exposure to high-growth, value-added categories. The capital expenditure for the year was approximately Rs. 52 crores. The Board has recommended the ratification of the remuneration payable to the Cost Auditor, Mr. Somnath Mukherjee, at Rs. 75,000 plus applicable taxes and expenses for the financial year 2026-27.
| Metric | FY26 |
|---|---|
| Revenue (Rs. crores) | 906 |
| Net Profit/Loss (Rs. crores) | (29) |
| Paper Production Growth | 2.3% |
| Chemical Production Growth | 6.7% |
| Value-added Product Mix | 55% |
| Projected Annual Savings (Project Sankalp) | Rs. 40 crores |
| New Tissue-4 Capacity | 23,400 TPA |
Historical Stock Returns for Orient Paper & Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.84% | -0.41% | -4.85% | -24.02% | -42.61% | -45.17% |
Will the projected Rs. 40 crores in annualized savings from Project Sankalp be sufficient to offset the 6% decline in average product prices and return the company to net profitability?
How will the addition of the new Tissue-4 machine impact the company's product mix, and will the shift toward tissue products help mitigate the pricing pressure seen in the Writing & Printing segment?
Can the positive cash flow achieved in Q4 FY26 be sustained into the coming quarters given the upcoming capital expenditures and operational ramp-up?































